Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01727076
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:48.284111+00:00
Published At
2017-09-15T00:00:00+00:00
Record Updated At
2017-09-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Head and Neck Squamous Cell Carcinoma", "Recurrent Head and Neck Carcinoma", "Recurrent Non-Small Cell Lung Carcinoma", "Recurrent Renal Cell Carcinoma", "Recurrent Skin Carcinoma", "Stage III Renal Cell Cancer", "Stage IIIA Cutaneous Melanoma AJCC v7", "Stage IIIA Non-Small Cell Lung Cancer AJCC v7", "Stage IIIB Cutaneous Melanoma AJCC v7", "Stage IIIB Non-Small Cell Lung Cancer AJCC v7", "Stage IIIC Cutaneous Melanoma AJCC v7", "Stage IV Cutaneous Melanoma AJCC v6 and v7", "Stage IV Non-Small Cell Lung Cancer AJCC v7", "Stage IV Renal Cell Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-09-15"
protocolSection.identificationModule.nctId
"NCT01727076"
protocolSection.identificationModule.officialTitle
"A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Squamous Cell Head and Neck Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Head and Neck Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Non-Small Cell Lung Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Skin Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Non-Small Cell Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Cutaneous Melanoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Non-Small Cell Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Renal Cell Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.